UroToday Hot Topics: Prostate cancer and urinary side effect

In September, the power of blue for prostate cancer awareness dominates UroToday’s online urology health news reports . [http://www.urotoday.com] “Prostate cancer research is at a new high as seen by the next generation drugs to treat metastatic prostate cancer. Not only is this hopeful for patients, men’s health will be positively impacted ,” says Gina Carithers, Publisher, UroToday. “We’re seeing a steady increase in readership from men with prostate cancer, as well as, the medical community, all eager for the latest news.“

As an online medical resource, UroToday has more than 10 years of scientific archived reports, representing 33 urology disease categories an. Current hot topics include prostate, bladder and renal cancers, and side effects impacting men and women (from male sexual dysfunction, incontinence, and CAUTI to overactive bladder).

This week UroToday launches the first in a series of monthly online professional lectures -- Advanced Treatments for Prostate Cancer -- by cancer researcher Chuck Ryan, MD, UCSF Medical Center. Dr. Ryan highlights the role of new drugs along with combination treatments to manage advanced prostate cancer. Of the nearly 250,000 newly diagnosed men In the U.S. this year, nearly 35,000 will be treated for metastatic castrate-resistant prostate cancer and 28,000 will die. UroToday will be expanding its editorial focus to report on a full-spectrum prostate disease issues including the PSA controversy, watchful waiting, and emerging surgical and non-surgical options, as well as, information about the urinary conditions that effect men’s sexual health.

“The UroToday multi-media case study is one of our most popular medical education features, added Carithers. “Our sister publication, the UroToday International (online) Journal, has in depth peer-reviewed articles on many urologic issues, not just prostate cancer, which enables the lesser known urologic diseases to have a platform of awareness and understanding.“

About UroToday.com
Gina Carithers, CEO and Publisher, Digital Science Press, Inc/UroToday founded the online urologic website in 2003 in Berkeley, CA. The worldwide medical resource focused on prostate, bladder and renal cancers and urologic health issues impacting men and women’s health, including catheter care. UroToday.com represents the largest online urology-oncology community. With more than 20 pages of new content daily, readers can access at no charge, but need to register at www.urotoday.com, UroToday International Journal is a sister-publications based on subscriptions and features peer-reviewed author submissions on case studies and medical review articles.

Media Contact
Gina Carithers
UroToday publisher
510.282.5000
Email Gcarithers@urotoday.com

Contact Information

Gina Carithers

Owner

UroToday.com

Contact via E-mail